The Undersecretary of Public Health, Paula Daza, announced this Saturday – amid the balance sheet on the situation of the pandemic in the country – changes to the Vaccination Calendar, related to the inclusion of two risk groups as of March 1: cancer patients and people with autoimmune disease and treatment with biological therapy.
“As of Monday, March 1, we are going to incorporate those who are with cancer, over the age of 16, and in treatment,” the health authority said.
“We’re going to incorporate all those people who have autoimmune disease and treatment with biological therapy and/or small molecules,” over the age of 16, he added.
These groups are added to dialysized patients (heme or peritoneum) over the age of 16 and those transplanted with solid organs (kidney, heart, liver, pancreas, lung), also from the age of 16.
“Chronic people in general can go to any vaccination center. Particularly people between the age of 16 and 18 who have some of these diseases that we have defined from Monday, such as people with cancer in treatment or autoimmune treatment, are the ones who should go to the centers where the Pfizer vaccine is,” Daza said, in relation to vaccination of these risk groups.
“This is because the Sinovac vaccine that we have massively has been approved for people over the age of 18, and the Pfizer vaccine for approval by the Institute of Public Health has been approved for people over the age of 16,” she explained.
From 3 March, meanwhile, the inoculation of the second doses of the vaccine will begin.
The calendar also includes preschool and school education workers, whose ages range from age 39 to 23 or younger, as detailed below.
